BeOne Medicines Ltd. — Director's Dealing 2019

Jul 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-06-27

Reporting Person: Huang Jane (CMO, Hematology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-27	American Depositary Shares	S	427	$124.5034	Disposed	3	Direct
2019-06-27	American Depositary Shares	S	3	$126.33	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	328873	Direct

Footnotes

F1: Each American Depositary Share ("ADS") represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover tax withholdings in connection with the vesting of a restricted share unit award previously granted to the Reporting Person.